SignatureFD’s Cymabay Therapeutics CBAY Stock Holding History

SignatureFD’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-365	Closed	-$8.62K	–	3278
2023 Q4	$8.62K	Buy	365 +164	+82%	+$2.92K	﹤0.01%	2325
2023 Q3	$3K	Buy	+201	New	+$2.67K	﹤0.01%	2667
2023 Q1	–	Sell	-116	Closed	-$727	–	3405
2022 Q4	$727	Buy	+116	New	+$441	﹤0.01%	3038
2021 Q4	–	Sell	-7,700	Closed	-$28K	–	3315
2021 Q3	$28K	Sell	7,700 -169	-2%	-$666	﹤0.01%	1607
2021 Q2	$34K	Sell	7,869 -646	-8%	-$2.86K	﹤0.01%	1472
2021 Q1	$39K	Buy	+8,515	New	+$45.8K	﹤0.01%	1290

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SignatureFD's CBAY Position: Q1 2024 in Review

SignatureFD sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 365 shares — an estimated $8.62K sold.

SignatureFD first reported a position in CBAY in Q1 2021 and held it in 6 quarters. The position peaked at $39K in Q1 2021. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

SignatureFD reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
SignatureFD sold 365 Cymabay Therapeutics shares in Q1 2024, an estimated $8.62K.
SignatureFD first reported a position in Cymabay Therapeutics in Q1 2021 and held it in 6 quarters.
SignatureFD's Cymabay Therapeutics position peaked at $39K in Q1 2021.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on SignatureFD's 13F filing for Q1 2024, filed 3 May 2024.